FHC
BMY.RT

First Horizon Corporation’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

First Horizon Corporation’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,472
Closed -$7K – 1288
2020
Q4 		$7K Sell
11,472
-66
-0.6% -$141 ﹤0.01% 754
2020
Q3 		$25K Buy
+11,538
New +$33K ﹤0.01% 456

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

First Horizon Corporation's BMY.RT Position: Q1 2021 in Review

First Horizon Corporation sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 11,472 shares — an estimated $7K sold.

First Horizon Corporation first reported a position in BMY.RT in Q3 2020 and held it in 2 quarters. The position peaked at $25K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • First Horizon Corporation reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • First Horizon Corporation sold 11,472 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $7K.
  • First Horizon Corporation first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q3 2020 and held it in 2 quarters.
  • First Horizon Corporation's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $25K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on First Horizon Corporation's 13F filing for Q1 2021, filed 11 May 2021.